Search

everythinglearnresearchcommunity

for

Search:↓

UVF-dermoscopy is a useful tool for accurately diagnosing types of alopecia, especially in people with lighter skin.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

The dye quickly penetrates hair follicles, mainly through the gap, not the surrounding skin.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

PRP preparation partially activates platelets, causing varied growth factor release.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

ABCG2 protein marks stem-like skin cells in human epidermis.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Compound 1 showed promising anticancer activity.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

FFA and FAPD might be related or stages of the same disease.

SVF treatment is more effective than Nanofat for hair growth.

A woman's small ovarian tumor causing high androgen levels was missed by several scans but found during surgery.

RADA-PDGF2 hydrogel speeds up wound healing and is safe for use.

EGFR hyperactivation increases sebaceous gland size and sebum production in mice.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

EGF–FGF2 helps mouse stem cells grow and become more like nerve cells.

CEC levels may be a useful marker for predicting prostate cancer progression.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

CGF therapy may help hair regrowth and improve scars in DLE patients.

Hair glycation could be a reliable non-invasive indicator of blood glucose control, but its use is limited by factors like sample collection and hair treatments.

Early changes in skin gene expression can predict later bone mass loss after radiation exposure.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Lymphangiosarcoma was confirmed in cats with specific skin symptoms using a lymphatic marker.